Should Infliximab be Used as an Adjuvant to IVIG in the Treatment of Children With Kawasaki Disease Who Are at High Risk for Resistance to Conventional Therapy?

Author: Davies Shelby   Gold-von Simson Gabrielle  

Publisher: Springer Publishing Company

ISSN: 0172-0643

Source: Pediatric Cardiology, Vol.34, Iss.7, 2013-10, pp. : 1756-1756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content